Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05255718 · ClinicalTrials.gov registry record · NA
Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome
A NA study, sponsored by Montana State University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05255718 is a NA study that has completed, run by Montana State University. The registered enrollment target is 13 participants.
The verdict
NCT05255718, a NA study, has completed, sponsored by Montana State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The goal of this project is to elucidate interactions between the gut microbiome, anti-inflammatory/anti-oxidant food metabolomic signatures, and human inflammation phenotypes. Inflammation plays both direct and indirect roles in the development of type 2 diabetes (T2D), atherogenic cardiovascular diseases, and other causes of morbidity and mortality. Aronia melanocarpa (Aronia berries) are rich in bioactive polyphenolic compounds, which have been shown to lower inflammation and favorably impact metabolism. However, there is tremendous inter-individual variability in the bioavailability of polyphenolics and production of bioactive phenolic metabolites in the colon that depends, at least in part, on digestive metabolism by the gut microbiota. Little is known about the complex interactions among the gut microbiome, anti-inflammatory food metabolomic signatures, and human inflammation phenotypes. This study will utilize a systems-level approach to disentangle these complex interactions. The specific study objectives are as follows: 1. to determine the impact of Aronia supplementation on inflammation, metabolic health, and gut microbiome composition 2. to determine the static and dynamic metabolomic signature of Aronia based on an Aronia supplementation period and responses to a high-fat meal challenge
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Aronia juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-04-27 |
| Est. Completion | 2019-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05255718
The ClinicalTrials.gov registry entry for NCT05255718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montana State University, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05255718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05255718 about?
NCT05255718 is a clinical study titled "Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome". The goal of this project is to elucidate interactions between the gut microbiome, anti-inflammatory/anti-oxidant food metabolomic signatures, and human inflammation phenotypes. Inflammation plays both direct and indirect roles in the development of type 2 diabetes (T2D), atherogenic cardiovascular d...
What is the current status of trial NCT05255718?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2019-04-27. Estimated completion is 2019-08-18.
What interventions are being tested in trial NCT05255718?
The interventions under investigation include: Placebo (OTHER), Aronia juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05255718?
This trial is sponsored by Montana State University, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.